Fact CheckerSign in

NCT07693816Recruiting

Early Identification and Diagnosis of BAD-related Stroke

Establishment and Validation of a Novel Intelligent Diagnostic Model for BAD-related Stroke Based on the Fusion of Multi-source Clinical Image Information and Its Promotion

Source: ClinicalTrials.gov · Last updated 9 Jul 2026

Brief summary (registry, in English)

Branch atheromatous disease (BAD)-related stroke is an important subtype of acute ischemic stroke involving penetrating arteries and is associated with early neurological deterioration. Early recognition and standardized diagnosis remain challenging in routine clinical practice because clinical symptoms are often non-specific and the diagnosis requires integrated clinical and imaging assessment. This multicenter prospective observational study will collect demographic, clinical, laboratory, electrocardiographic, ultrasound, and multimodal neuroimaging data from adults with acute ischemic stroke within 1 week of symptom onset. Participants will receive routine clinical care determined by their treating physicians; no treatment or management strategy will be assigned by the study protocol. An independent central clinical-imaging adjudication committee will classify participants as BAD-related stroke or non-BAD acute ischemic stroke according to predefined diagnostic criteria. The study aims to develop and externally validate artificial intelligence-assisted screening and diagnostic models for BAD-related stroke and to evaluate their discrimination, calibration, and potential clinical utility.

Status (registry)
Recruiting
Study type
Observational
Enrollment
1602 (estimated)
First submitted
5 Jul 2026
Start date
15 Jul 2026
Primary completion date
31 Jan 2028
Lead sponsor
Peking Union Medical College Hospital
Diseases
Stroke
NCT number
NCT07693816

What you commit to

  • Study type: Observational
  • Planned participants: 1602
  • From 15 Jul 2026 to the primary completion date, 31 Jan 2028
  • 11 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Participation in another clinical study within 3 months before informed consent or current participation in another clinical study that may interfere with this study.
    • Additional criteria that preclude classification as BAD-related stroke:

Other illness

  • Intracranial hemorrhage, vascular malformation, aneurysm, brain abscess, malignant intracranial mass, or other non-ischemic intracranial lesion on baseline CT, MRI, MRA, CTA, or DSA.
  • Pre-stroke modified Rankin Scale score ≥2.
  • Definite cardioembolic source, including atrial fibrillation, myocardial infarction, clinically significant valvular heart disease, dilated cardiomyopathy, infective endocarditis, atrioventricular conduction disease, or heart rate \<50 beats/min as defined in the protocol.
  • Receipt of or planned acute-phase endovascular treatment after stroke onset.
  • Stroke due to other determined causes, such as moyamoya disease, arterial dissection, or vasculitis.

Other

  • General exclusion criteria for all participants:
  • Life expectancy ≤6 months.
  • Unable to tolerate MRI examination.
  • Pregnancy or breastfeeding.
  • Ipsilateral extracranial tandem artery stenosis ≥50%.

Who the study is looking for

  • Age 18 to 80 years.
  • Diagnosis of acute ischemic stroke.
  • Time from symptom onset to enrollment ≤ 1 week; if the onset time is unknown, time from last known well to enrollment ≤ 1 week.
  • Availability of required baseline clinical and neuroimaging assessments according to the study protocol.
  • Written informed consent provided by the participant or legally authorized representative.
    • Participants will be classified into the BAD-related stroke cohort if they meet all predefined BAD-related stroke diagnostic criteria, including:
  • A single isolated deep subcortical infarct on diffusion-weighted imaging.
  • The presumed culprit perforating artery is the lenticulostriate artery or the paramedian pontine artery.
  • For lenticulostriate artery territory infarction: a comma-shaped lesion extending from inferior to superior direction on coronal DWI or involvement of ≥3 axial DWI slices with 5-7 mm slice thickness.
  • For paramedian pontine artery territory infarction: a lesion extending from the deep pons to the ventral surface of the pons on axial DWI.
  • No ≥50% stenosis of the corresponding parent artery, confirmed by MRA, CTA, or DSA.
    • Participants with acute ischemic stroke who do not meet BAD-related stroke criteria will be classified into the non-BAD acute ischemic stroke cohort.

Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (11)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Beijing Shijingshan Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Jingmei Group General Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Sixth Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Yanqing District Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Puren Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Fangshan District Liangxiang Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Huaxin Hospital (The First Hospital of Tsinghua University)
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Longfu Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Shijitan Hospital, Capital Medical University
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Beijing Haidian Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting
Peking Union Medical College Hospital
Coordinator of this site? Confirm its status
BeijingChinaRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.